##gff-version 3
##sequence-region Q86WB0 1 502
Q86WB0	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895;Dbxref=PMID:19413330,PMID:22223895	
Q86WB0	UniProtKB	Chain	2	502	.	.	.	ID=PRO_0000096849;Note=Nuclear-interacting partner of ALK	
Q86WB0	UniProtKB	Zinc finger	102	156	.	.	.	Note=C3HC-type	
Q86WB0	UniProtKB	Region	170	210	.	.	.	Note=F-box-like	
Q86WB0	UniProtKB	Motif	396	402	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12748172;Dbxref=PMID:12748172	
Q86WB0	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895;Dbxref=PMID:19413330,PMID:22223895	
Q86WB0	UniProtKB	Modified residue	24	24	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:17081983,PMID:20068231,PMID:21406692,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	28	28	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:17081983,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	58	58	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:21406692,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	84	84	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86WB0	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18220336,PMID:18691976,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q86WB0	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q86WB0	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
Q86WB0	UniProtKB	Modified residue	344	344	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q86WB0	UniProtKB	Modified residue	354	354	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:12748172;Dbxref=PMID:18669648,PMID:19690332,PMID:21406692,PMID:23186163,PMID:24275569,PMID:12748172	
Q86WB0	UniProtKB	Modified residue	359	359	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q86WB0	UniProtKB	Modified residue	370	370	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
Q86WB0	UniProtKB	Modified residue	381	381	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86WB0	UniProtKB	Modified residue	384	384	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q86WB0	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:23186163	
Q86WB0	UniProtKB	Modified residue	407	407	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q86WB0	UniProtKB	Modified residue	483	483	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86WB0	UniProtKB	Alternative sequence	1	49	.	.	.	ID=VSP_015217;Note=In isoform 2. MAAPCEGQAFAVGVEKNWGAVVRSPEGTPQKIRQLIDEGIAPEEGGVDA->MRGLPRKREAWTQPHPLEALYESLRVLE;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q86WB0	UniProtKB	Alternative sequence	341	411	.	.	.	ID=VSP_015218;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11042152;Dbxref=PMID:11042152	
Q86WB0	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_023312;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs1464890,PMID:15489334	
Q86WB0	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_023313;Note=R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs11556924,PMID:15489334	
Q86WB0	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Does not strongly affect phosphorylation status%3B when associated with F-137. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12748172;Dbxref=PMID:12748172	
Q86WB0	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Does not strongly affect phosphorylation status%3B when associated with F-105. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12748172;Dbxref=PMID:12748172	
Q86WB0	UniProtKB	Mutagenesis	170	171	.	.	.	Note=Abolishes interaction with SKP1. LP->FM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16009132;Dbxref=PMID:16009132	
Q86WB0	UniProtKB	Mutagenesis	354	354	.	.	.	Note=Strongly reduces phosphorylation and induces the formation of a constitutive SCF(NIPA) E3 complex that degrades CCNB1 at G2/M phase and delays mitotic entry. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12748172,ECO:0000269|PubMed:16009132;Dbxref=PMID:12748172,PMID:16009132	
Q86WB0	UniProtKB	Mutagenesis	398	401	.	.	.	Note=Induces a complete cytoplasmic redistribution. RKAK->AAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12748172;Dbxref=PMID:12748172	
Q86WB0	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Induces a partial cytoplasmic redistribution. K->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12748172;Dbxref=PMID:12748172	
Q86WB0	UniProtKB	Sequence conflict	179	179	.	.	.	Note=V->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86WB0	UniProtKB	Sequence conflict	278	278	.	.	.	Note=K->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
